Patents by Inventor Steve Holmes

Steve Holmes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200083398
    Abstract: A semiconductor device includes a substrate and a buffer layer disposed on a first portion, a second portion, and a third portion of the substrate. The semiconductor device further includes a multilayer light-emitting diode (LED) stack disposed on the first portion of the substrate, and an optical sensor disposed on the second portion of the substrate. The semiconductor device further includes at least one electrode disposed on the third portion of the substrate, a first conductor in contact with the multilayer LED stack, and a second conductor in contact with the optical sensor. The at least one electrode, the first conductor, and the second conductor are formed of a glassy carbon material.
    Type: Application
    Filed: November 13, 2019
    Publication date: March 12, 2020
    Applicant: International Business Machines Corporation
    Inventors: Steve Holmes, Devendra Sadana, Stephen W. Bedell, Bruce Doris, Hariklia Deligianni, Jia Chen
  • Patent number: 10566493
    Abstract: A semiconductor device includes a substrate and a buffer layer disposed on a first portion, a second portion, and a third portion of the substrate. The semiconductor device further includes a multilayer light-emitting diode (LED) stack disposed on the first portion of the substrate, and an optical sensor disposed on the second portion of the substrate. The semiconductor device further includes at least one electrode disposed on the third portion of the substrate, a first conductor in contact with the multilayer LED stack, and a second conductor in contact with the optical sensor. The at least one electrode, the first conductor, and the second conductor are formed of a glassy carbon material.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: February 18, 2020
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Steve Holmes, Devendra Sadana, Stephen W. Bedell, Bruce Doris, Hariklia Deligianni, Jia Chen
  • Publication number: 20200044113
    Abstract: A semiconductor device includes a substrate and a buffer layer disposed on a first portion, a second portion, and a third portion of the substrate. The semiconductor device further includes a multilayer light-emitting diode (LED) stack disposed on the first portion of the substrate, and an optical sensor disposed on the second portion of the substrate. The semiconductor device further includes at least one electrode disposed on the third portion of the substrate, a first conductor in contact with the multilayer LED stack, and a second conductor in contact with the optical sensor. The at least one electrode, the first conductor, and the second conductor are formed of a glassy carbon material.
    Type: Application
    Filed: July 31, 2018
    Publication date: February 6, 2020
    Applicant: International Business Machines Corporation
    Inventors: Steve Holmes, Devendra Sadana, Stephen W. Bedell, Bruce Doris, Hariklia Deligianni, Jia Chen
  • Publication number: 20190315876
    Abstract: The present invention relates to antigen binding molecules, including antibodies, fragments, and variants thereof, that bind to the TNF-related cytokine LIGHT (TNFSF14). The present invention also relates to methods of use of such antigen binding molecules in treating and/or preventing inflammatory disorders and immune disorders.
    Type: Application
    Filed: January 24, 2019
    Publication date: October 17, 2019
    Inventor: Steve Holmes
  • Patent number: 10420982
    Abstract: System and methods are provided for prompting a user to perform an exercise and to monitor the exercise. The form of the user may be monitored, such as with one or more video cameras and/or other sensors, to determine how well the user is performing the exercise. Energy expenditure is estimated based factors that include the type of the exercise, the form of the user and a contribution value that associates energy expenditure with form.
    Type: Grant
    Filed: June 4, 2013
    Date of Patent: September 24, 2019
    Assignee: NIKE, Inc.
    Inventors: Tesa Aragones, Adriana Guerrero, Steve Holmes, Christina S. Self, Aaron B. Weast, Paul Winsper, Jay C. Blahnik, Adam Carroll
  • Patent number: 10388857
    Abstract: A magnetoresistive memory cell includes a magnetic tunnel junction pillar having a circular cross section. The pillar has a pinned magnetic layer, a tunnel barrier layer, and a free magnetic layer. A first conductive contact is disposed above the magnetic tunnel junction pillar. A second conductive contact is disposed below the magnetic tunnel junction pillar.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: August 20, 2019
    Assignee: International Business Machines Corporation
    Inventors: Anthony J. Annunziata, Armand A. Galan, Steve Holmes, Eric A. Joseph, Gen P. Lauer, Qinghuang Lin, Nathan P. Marchack
  • Patent number: 10369412
    Abstract: Systems and methods for prompting a user to perform an exercise and monitoring the exercise are provided. Multiple independent sensors or sensor systems may be used to calculate energy expenditure. Various criteria may be used to manually or automatically select the independent sensor or sensor system or combination that will be used with the energy expenditure calculations.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: August 6, 2019
    Assignee: NIKE, Inc.
    Inventors: Tesa Aragones, Adriana Guerrero, Steve Holmes, Christina S. Self, Aaron B. Weast, Paul Winsper, Jay C. Blahnik
  • Patent number: 10259880
    Abstract: The present invention relates to anti-human LIGHT antibodies, new medical uses and methods.
    Type: Grant
    Filed: January 13, 2015
    Date of Patent: April 16, 2019
    Assignee: KYMAB LIMITED
    Inventors: Jamie Iain Campbell, Bettina Franz, Steve Holmes, Ian Kirby, Anais Legent
  • Patent number: 10213647
    Abstract: Systems, apparatuses, and methods for determining when an athlete is in possession of a ball by analyzing image data are provided. A camera is worn by an athlete and is turned on when the athlete is in proximity of a ball. The camera is used to generate an image of a ball. The size of the ball is determined and compared to a threshold. The athlete is considered to be in possession of the ball when the size of the image exceeds the threshold.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: February 26, 2019
    Assignee: NIKE, Inc.
    Inventors: SantoshKumar Balakrishnan, Steve Holmes, Aaron B. Weast
  • Patent number: 10170698
    Abstract: A method of forming a pillar includes masking a photoresist material using a reticle and a developer having a polarity opposite that of the photoresist to provide an island of photoresist material. A layer under the island of photoresist material is etched to establish a pillar defined by the island of photoresist material.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: January 1, 2019
    Inventors: Anthony J. Annunziata, Armand A. Galan, Steve Holmes, Eric A. Joseph, Gen P. Lauer, Qinghuang Lin, Nathan P. Marchack
  • Publication number: 20180268113
    Abstract: Example embodiments may relate to a system, method, apparatus, and computer readable media configured for prompting a user to perform an exercise, monitoring form of the user while performing the exercise, and calculating an energy expenditure estimate for the user performing the exercise based on a type of the exercise and on the form of the user.
    Type: Application
    Filed: October 23, 2017
    Publication date: September 20, 2018
    Inventors: Tesa Aragones, Adriana Guerrero, Steve Holmes, Christina S. Self, Aaron B. Weast, Paul T. Winsper, Jay C. Blahnik
  • Publication number: 20180142023
    Abstract: Disclosed are domain antibodies that monovalently bind CD28. Domain antibodies that are monovalent for binding of CD28 can inhibit CD28 activity. In one aspect, a domain antibody consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28, in an aspect, without substantially agonizing CD28 activity. In another aspect, the domain antibody is a human domain antibody. The disclosure further encompasses methods of antagonizing CD80 and/or CD86 interactions with CD28 in an individual and methods of treating diseases or disorders involving CD80 and/or CD86 interactions with CD28, the methods involving administering a domain antibody to the individual.
    Type: Application
    Filed: January 12, 2018
    Publication date: May 24, 2018
    Inventors: Murray McKinnon, Steven G. Nadler, Suzanne J. Suchard, Brendan Classon, Steve Holmes, Olga Ignatovich, Christopher Plummer, Steve Grant
  • Patent number: 9908937
    Abstract: Disclosed are domain antibodies that monovalently bind CD28. Domain antibodies that are monovalent for binding of CD28 can inhibit CD28 activity. In one aspect, a domain antibody consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28, in an aspect, without substantially agonizing CD28 activity. In another aspect, the domain antibody is a human domain antibody. The disclosure further encompasses methods of antagonizing CD80 and/or CD86 interactions with CD28 in an individual and methods of treating diseases or disorders involving CD80 and/or CD86 interactions with CD28, the methods involving administering a domain antibody to the individual.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: March 6, 2018
    Assignees: Bristol-Myers Squibb Company, Domantis Limited
    Inventors: Murray McKinnon, Steven G. Nadler, Suzanne J. Suchard, Brendan Classon, Steve Holmes, Olga Ignatovich, Christopher Plummer, Steve Grant
  • Publication number: 20180060532
    Abstract: Example embodiments may relate to a system, method, apparatus, and computer readable media configured for prompting a user to perform an exercise, monitoring form of the user while performing the exercise, and calculating an energy expenditure estimate for the user performing the exercise based on a type of the exercise and on the form of the user.
    Type: Application
    Filed: October 23, 2017
    Publication date: March 1, 2018
    Inventors: Tesa Aragones, Adriana Guerrero, Steve Holmes, Christina S. Self, Aaron B. Weast, Paul T. Winsper, Jay C. Blahnik
  • Patent number: 9868790
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: January 16, 2018
    Assignee: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • Patent number: 9868789
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: January 16, 2018
    Assignee: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • Patent number: 9852271
    Abstract: Example embodiments may relate to a system, method, apparatus, and computer readable media configured for prompting a user to perform an exercise, monitoring form of the user while performing the exercise, and calculating an energy expenditure estimate for the user performing the exercise based on a type of the exercise and on the form of the user.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: December 26, 2017
    Assignee: NIKE, Inc.
    Inventors: Tesa Aragones, Adriana Guerrero, Steve Holmes, Christina S. Self, Aaron B. Weast, Paul T. Winsper, Jay C. Blahnik
  • Publication number: 20170327586
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 16, 2017
    Applicant: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell
  • Publication number: 20170327587
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 16, 2017
    Applicant: Kymab Limited
    Inventors: Jamie Campbell, Steve Holmes, Ian Kirby, Miha Kosmac
  • Publication number: 20170260279
    Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
    Type: Application
    Filed: May 24, 2017
    Publication date: September 14, 2017
    Applicant: Kymab Limited
    Inventors: Philip Bland-Ward, Miha Kosmac, Steve Holmes, Ian Kirby, Jamie Campbell